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What is appropriate fetal surveillance 
for women with diet-controlled 
gestational diabetes?
■ Evidence summary
Gestational diabetes mellitus is diagnosed
when at least 2 of 4 values measured in a
3-hour glucose tolerance test are elevated;
2 different definitions of “elevated” are
accepted (TABLE 1). White’s classification
stratifies the risk of various types of dia-
betes during pregnancy (TABLE 2): Class A
includes patients without a diagnosis of
diabetes before pregnancy; classes B, C,
and D include patients with pre-existing
diabetes of increasing duration; and 
classes F, H, R, and T include patients
with diabetes with various vascular 
complications.
Infants of mothers with pre-existing
diabetes are at increased risk of pre- and
neonatal complications (including still-
birth); it has been commonly assumed
that type A1 gestational diabetes confers
similar risks. However, 2 observational
studies call this assumption into question.
One study evaluated antepartum predic-
tors of fetal distress requiring a cesarean
delivery among 2134 pregnant women
with gestational diabetes.4 Antepartum
surveillance consisted of biweekly non-
stress testing with amniotic fluid index
determination starting at 34 weeks gesta-
tion. Of the 1501 eligible participants, 
the study included 810 and 580 class A1
and A2 patients, respectively; the remain-
ing 111 were classes B–T. They consid-
ered women with A1 gestational diabetes
with fasting plasma glucose levels <105
mg/dL to be well-controlled. Results of
No evidence clearly supports the practice of
increased fetal surveillance in the pregnancies of
women with well-controlled (ie, fasting blood
sugar <105 mg/dL) class A1 gestational diabetes
(strength of recommendation [SOR]: B, consistent
retrospective cohort studies). However, a number
of guidelines recommend beginning surveillance
of some kind between 32 and 40 weeks based on
cumulative risk factors, including gestational 
diabetes (SOR: C, expert opinion).
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C L I N I C A L C O M M E N T A R Y
Follow local standards of care 
and continue fetal surveillance
Because malpractice issues weigh heavy in many
states, a Family Physician who practices obstetrics
may be liable even when a patient is at low risk.
We know diabetes has devastating effects on
patients. Why would there not be risk with gesta-
tional diabetes? The findings in this Clinical Inquiry
provide practicing doctors little evidence for or
against antenatal testing for women with 
gestational diabetes. I agree more research is
needed to reassure physicians that increased fetal
surveillance does not make a difference in fetal or
maternal outcomes. Until that time, it would seem
prudent to find out what your local standards of
care would be—possibly non-stress testing or 
biophysical profiles during 32 to 40 weeks—and
continue your fetal surveillance.
Julia Fashner, MD
Piqua, OH
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Gestational 
diabetes alone
may not confer
increased risk 
for neonatal 
complications
FAST TRACK
antepartum surveillance did not signifi-
cantly differ among the different diabetic
classes. 
In univariate and multivariate analy-
ses, the greatest indicator for cesarean
section due to fetal distress was a non-
reactive non-stress test with decelerations
(odds ratio [OR]=5.63; 95% confidence
interval [CI], 2.67–11.9). Routine amni-
otic fluid measurement was not signifi-
cantly related to either the classification
of diabetes or to cesarean delivery for
fetal distress. No patients with normal
surveillance testing within 4 days of deliv-
ery had a stillbirth. However, all 5 still-
births in the study population occurred
among those with A2 diabetes whose last
non-stress test was >4 days prior.
An earlier retrospective study fol-
lowed 97 pregnant patients with 
gestational diabetes, 69 of whom were
diet-controlled (class A1, fasting glucose
<105 mg/dL).5 Antepartum surveillance
consisted of maternal monitoring and
non-stress testing. At 28 weeks, pregnant
patients assessed daily fetal activity; reas-
suring fetal well-being was defined as 10
fetal movements in a 12-hour period. At
40 weeks, a non-stress test was performed
weekly. Contraction stress testing was
performed for those with nonreactive
non-stress tests. To observe for macro-
somia, serial ultrasonography was per-
formed every 4 to 6 weeks, starting at 28
weeks. Forty-four patients (64%) had
spontaneous labors without intervention,
while the rest required induction of labor
or cesarean section (primary or failed
induction). Five patients had primary
cesarean section for suspected macroso-
mia, 3 patients had intervention for sus-
pected intrauterine growth restriction, and
only 4 (5.7%) patients were delivered due
to fetal indications, defined as decreased
fetal movement or a nonreactive non-
stress test. No stillbirths or neonatal
deaths occurred. Perinatal complications
included hypoglycemia (n=13; 19%),
hyperbilirubinemia (n=12; 17%), and
macrosomia (n=11; 16%). The study did
not compare complication rates between
diet-controlled and insulin-requiring
patients (SOR: B, retrospective study).
A Cochrane review found no evi-
dence for or against increased surveillance
in A1 gestational diabetes: “A lack of
conclusive evidence has lead clinicians to
equate the risk of adverse perinatal out-
come with pre-existing diabetes.
Consequently women are often managed
with increased obstetrical monitoring,
dietary regulation, and [pharmacological]
treatment. However, no sound evidence
base supports such intensive treatment.”6
Recommendations from others
The American College of Obstetricians
and Gynecologists’ practice bulletin on
T A B L E
PLASMA OR SERUM GLUCOSE LEVEL PLASMA LEVEL DATA
(CARPENTER/COUSTAN CONVERSION (NATIONAL DIABETES GROUP CONVERSION
AMERICAN DIABETES ASSOCIATION)1 AMERICAN COLLEGE OF OB/GYN)2
STATUS MG/DL MMOL/L MG/DL MMOL/L
Fasting 95 5.3 105 5.8
1 hour 180 10.0 190 10.6
2 hours 155 8.6 165 9.2
3 hours 140 7.8 145 8.0
At least 2 of 4 measurements over 3 hours must be higher than
these values to diagnose gestational diabetes mellitus
gestational diabetes states that there is no
consensus regarding fetal surveillance for
women with diet-controlled gestational
diabetes. However, local practice may
include non-stress and contraction stress
testing, amniotic fluid determination, and
biophysical profile; this may start as early
as 32 weeks to or as late as 40 weeks,
based upon the total cumulative risk 
to the fetus from all potential compli-
cations.2 The American Diabetes
Association states that increased fetal sur-
veillance is appropriate but is not any
more specific with this recommendation.1
R E F E R E N C E S
1. American Diabetes Association. Gestational diabetes
mellitus. Diabetes Care 2004; 27(suppl 1):S88–S90.
2. American College of Obstetricians and Gynecologists
Committee on Practice Bulletins—Obstetrics. ACOG
Practice Bulletin. Clinical Management Guidelines for
Obstetrician-Gynecologists. Gestational diabetes.
Obstet Gynecol 2001; 98:525–538.
3. White P. Classification of obstetric diabetes. Am J
Obstet Gynecol 1978; 130:228–230.
4. Kjos SL, Leung A, Henry OA, Victor MR, Paul RH,
Medearis AL. Antepartum surveillance in diabetic
pregnancies: Predictors of fetal distress in labor. Am J
Obstet Gynecol 1995; 173:1532–1539.
5. Landon MB, Gabbe SG. Antepartum fetal surveillance
in gestational diabetes mellitus. Diabetes 1985;
34(Suppl 2):50–54.
6. Tuffnell DJ, West J, Walkinshaw SA. Treatments for
gestational diabetes and impaired glucose tolerance in
pregnancy. Cochrane Database Syst Rev 2003;
(3):CD003395.
The greatest 
indicator for
cesarean section
due to fetal 
distress was 
a non-reactive
non-stress 
test with 
decelerations
240 VOL 55, NO 3 / MARCH 2006  THE JOURNAL OF FAMILY PRACTICE
CLINICAL INQUIRIES
FAST TRACK
T A B L E
CLASS DEFINITION
A1 Diabetes diagnosed during pregnancy; non-insulin-dependent
A2 Diabetes diagnosed during pregnancy; insulin-dependent
B Diabetes diagnosed after age 20 years or duration less than 10 years; 
no vascular complications
C Diabetes diagnosed between age 10 to 19 years or duration 
of 10 to 19 years; no vascular complications
D Diabetes diagnosed before age of 10 years or duration greater 
than 20 years; vascular complications present
F Diabetes with nephropathy
H Diabetes with coronary artery or other heart disease
R Diabetes with retinopathy
T Diabetes status post–renal transplant
White’s classification for gestational diabetes mellitus
